Consolidated Income Statement

28 KB EXCEL


€ million Note 2017 2016
Net sales ➞ 7 15,327 15,024
Cost of sales ➞ 8 – 5,320 – 5,201
(of which: amortization of intangible assets)1 (– 179) (– 181)
Gross profit 10,007 9,823
     
Marketing and selling expenses ➞ 9 – 4,702 – 4,526
(of which: amortization of intangible assets)1 (– 1,017) (– 1,032)
Administration expenses – 930 – 854
Research and development costs ➞ 10 – 2,140 – 1,976
(of which: amortization of intangible assets)1 (– 5) (– 4)
Other operating income ➞ 11 1,227 996
Other operating expenses ➞ 12 – 937 – 981
Operating result (EBIT)2 2,525 2,481
       
Financial result ➞ 13 – 300 – 326
Profit before income tax 2,224 2,154
       
Income tax ➞ 14 386 – 521
Profit after tax 2,610 1,633
       
of which: attributable to shareholders of Merck KGaA, Darmstadt, Germany (net income) 2,600 1,629
of which: attributable to non-controlling interests ➞ 25 10 4
       
Earnings per share (in €) ➞ 15
basic 5.98 3.75
diluted 5.98 3.75
1
Excluding amortization of internally generated or separately acquired software.
2
Not defined by International Financial Reporting Standards (IFRS).